Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Moscow Exchange admits Rusagro shares to trading

2/14/25 RAGR

Samolet summarised the work in 2024

2/14/25 SMLT

Artgen has agreed a strategic partnership with the Skolkovo Foundation

2/14/25 ABIO

Russneft reported for 2024 by RAS

2/14/25 RNFT

MTS increased its stake in MTS Yurent to 84.6%

2/14/25 MTSS

Production is recovering at Rosneft's foreign project

2/14/25 ROSN

VK buys 25% of P7 developer

2/14/25 VKCO

Moscow Exchange was unable to hold an evening session

2/14/25 MOEX

PhosAgro sales in 2024 grow by 4.2%

2/13/25 PHOR

Board of Directors of Phosagro recommended that dividends be paid for 2024

2/13/25 PHOR